PlumX Metrics
Embed PlumX Metrics

A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19

European Respiratory Journal, ISSN: 1399-3003, Vol: 58, Issue: 4
2021
  • 39
    Citations
  • 0
    Usage
  • 63
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Letter Description

European Respiratory Journal

Bibliographic Details

Singh, Dave; Bogus, Maxim; Moskalenko, Valentyn; Lord, Robert; Moran, Edmund J; Crater, Glenn D; Bourdet, David L; Pfeifer, Nathan D; Woo, Jacky; Kaufman, Elad; Lombardi, David A; Weng, Emily Y; Nguyen, Tuan; Woodcock, Ashley; Haumann, Brett; Saggar, Rajeev

European Respiratory Society (ERS)

Medicine

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know